It is estimated that 176,000,000 women worldwide have endometriosis ( 2 )
Looking forward, the GLP-1 drugs we study (semaglutide, tirzepatide, and emerging oral formulations like orforglipron) are likely only the beginning of a new wave of chronic therapies for conditions like obesity, heart failure, and even kidney disease
Patent and Trademark Office (USPTO) agreed to review the validity of a Novo Nordisk patent on Ozempic and Wegovy at the request of generic drug maker Mylan Pharmaceuticals
These injectable medications may be beneficial for individuals who have struggled to achieve meaningful weight loss through traditional methods alone
Key verification standards to look for when sourcing BPC-157: Certificate of Analysis (CoA) documentation from the manufacturer confirming peptide identity, purity, and composition